Quality Improvement in the Practice of Blood Transfusions in Transcatheter Aortic Valve Implantation Procedures

Background Transcatheter aortic valve implantation (TAVI) is a standard procedure for symptomatic severe aortic stenosis and is especially favored in patients with a high surgical risk. Although TAVI is minimally invasive, blood transfusion remains a relevant postoperative concern. Glenfield Hospital routinely cross-matched four units of packed red cells (PRCs) for every TAVI patient. This practice put significant strain on transfusion services and hospital resources with the increased volume of TAVIs performed, from 182 cases in 2021 to 543 in 2024. Changes in data regarding blood transfusion demands allowed for changing the practice to cross-matching only two units of PRCs for non-surgical transfemoral TAVI patients starting June 2024. This study aimed to assess the safety and cost implications before and after implementing the revised blood cross-matching protocols for non-surgical transfemoral TAVI patients. Methodology A retrospective study was performed among all TAVI cases at Glenfield Hospital from June 1 to December 31, 2024. The study used the National Institute for Cardiovascular Outcomes Research TAVI database. Patients were split into different groups according to approach (non-surgical transfemoral access vs. surgical access). The primary aim was measurement of the transfusion rate and the number of units transfused after the TAVI procedure, and the secondary aim was to assess the safety and cost implications before and after implementing the revised blood cross-matching protocols for non-surgical transfemoral TAVI patients. Results Out of 312 patients (mean age = 81 ± 6 years; 39% female), 94% received non-surgical transfemoral TAVI. Only four (1.28%) patients required PRC transfusion. Only one (0.32%) patient required more than two units following vascular closure device failure, requiring surgical repair. Conclusions This single-center study offers evidence to justify the modified practice of limiting cross-matching of blood to two PRC units, or doing group and save only, in non-surgical transfemoral TAVI patients. The practice is safe as well as cost-effective and leads to significant cost savings without compromising patient care. However, further multicenter, prospective studies with long-term follow-up are justified to replicate these findings and establish broader implications for patient care.